January 4, 2023

PITTSBURGH – Jan. 3, 2023 – Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life
Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris’ strategic update. Former Oyster Point Pharma CEO, Jeffrey Nau,
Ph.D., MMS, will lead the new division. FLG partner Mark Murray was CFO at Oyster Point from 2015 through the company’s IPO and has been a Board Member since 2017.

Full press release is here.